Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preserving Healthy Muscle during Weight Loss
Edda Cava, Nai Chien Yeat, Bettina Mittendorfer
Advances in Nutrition (2017) Vol. 8, Iss. 3, pp. 511-519
Open Access | Times Cited: 288

Showing 1-25 of 288 citing articles:

Sarcopenia
Alfonso J. Cruz‐Jentoft, Avan Aihie Sayer
The Lancet (2019) Vol. 393, Iss. 10191, pp. 2636-2646
Closed Access | Times Cited: 2593
Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity
Dylan A Lowe, Nancy Wu, Linnea Rohdin-Bibby, et al.
JAMA Internal Medicine (2020) Vol. 180, Iss. 11, pp. 1491-1491
Open Access | Times Cited: 395
High rates of central obesity and sarcopenia in CKD irrespective of renal replacement therapy – an observational cross-sectional study
Jutta Dierkes, Helene Dahl, Natasha Lervaag Welland, et al.
BMC Nephrology (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 238
Sarcopenic obesity: Time to meet the challenge
Rocco Barazzoni, Stephan C. Bischoff, Yves Boirie‌, et al.
Clinical Nutrition (2018) Vol. 37, Iss. 6, pp. 1787-1793
Open Access | Times Cited: 216
Effect of Ramadan Fasting on Weight and Body Composition in Healthy Non-Athlete Adults: A Systematic Review and Meta-Analysis
Hamish A. Fernando, Jessica Zibellini, Rebecca A. Harris, et al.
Nutrients (2019) Vol. 11, Iss. 2, pp. 478-478
Open Access | Times Cited: 214
Clinical application of intermittent fasting for weight loss: progress and future directions
Krista A Varady, Sofia Cienfuegos, Mark Ezpeleta, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 5, pp. 309-321
Closed Access | Times Cited: 211
Sarcopenic Obesity: Time to Meet the Challenge
Rocco Barazzoni, Stephan C. Bischoff, Yves Boirie‌, et al.
Obesity Facts (2018) Vol. 11, Iss. 4, pp. 294-305
Open Access | Times Cited: 186
Beneficial Effects of Time-Restricted Eating on Metabolic Diseases: A Systemic Review and Meta-Analysis
Shinje Moon, Jiseung Kang, Sang Hyun Kim, et al.
Nutrients (2020) Vol. 12, Iss. 5, pp. 1267-1267
Open Access | Times Cited: 180
Effect of Weight Loss on Upper Airway Anatomy and the Apnea–Hypopnea Index. The Importance of Tongue Fat
Stephen Wang, Brendan T Keenan, Andrew Wiemken, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 201, Iss. 6, pp. 718-727
Open Access | Times Cited: 153
The magnitude and progress of lean body mass, fat‐free mass, and skeletal muscle mass loss following bariatric surgery: A systematic review and meta‐analysis
Malou A. H. Nuijten, Thijs M.H. Eijsvogels, Valerie M. Monpellier, et al.
Obesity Reviews (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 107
Changes in lean body mass with glucagon‐like peptide‐1‐based therapies and mitigation strategies
Ian J. Neeland, Jennifer Linge, Andreas L. Birkenfeld
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S4, pp. 16-27
Closed Access | Times Cited: 38
Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism
Elizabeth de Fougerolles Nunn, Natasha Jaiswal, Matthew Gavin, et al.
Molecular Metabolism (2024) Vol. 80, pp. 101880-101880
Open Access | Times Cited: 23
A systematic review of the effect of semaglutide on lean mass: insights from clinical trials
Alexia Bikou, Foteini Dermiki‐Gkana, Michail Penteris, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 5, pp. 611-619
Closed Access | Times Cited: 16
Strategies for minimizing muscle loss during use of incretin‐mimetic drugs for treatment of obesity
Jeffrey I. Mechanick, W. Scott Butsch, Sandra M. Christensen, et al.
Obesity Reviews (2024)
Open Access | Times Cited: 16
Double burden of malnutrition in persons with obesity
Rocco Barazzoni, Gianluca Gortan Cappellari
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 21, Iss. 3, pp. 307-313
Open Access | Times Cited: 72
Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study
Sara Volpe, Giuseppe Lisco, Margherita Fanelli, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 32
Cardiovascular Disease in Saudi Arabia: facts and the way forward
Adel Tash, Rasha Al‐Bawardy
Journal of the Saudi Heart Association (2023) Vol. 35, Iss. 2, pp. 148-162
Open Access | Times Cited: 30
Defining and diagnosing sarcopenia: Is the glass now half full?
Rocco Barazzoni, Tommy Cederholm, Michela Zanetti, et al.
Metabolism (2023) Vol. 143, pp. 155558-155558
Open Access | Times Cited: 23
Association of low muscle mass and obesity with increased all‐cause and cardiovascular disease mortality in US adults
Donghyun Kim, Junghoon Lee, Raekil Park, et al.
Journal of Cachexia Sarcopenia and Muscle (2023)
Open Access | Times Cited: 22
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation
Konstantinos Stefanakis, Michail Kokkorakis, Christos S. Mantzoros
Metabolism (2024), pp. 156057-156057
Closed Access | Times Cited: 15
Does early time-restricted eating reduce body weight and preserve fat-free mass in adults? A systematic review and meta-analysis of randomized controlled trials
Mengyu He, Bo Li, Ming Li, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 2, pp. 102952-102952
Closed Access | Times Cited: 8
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
Jennifer Linge, Andreas L. Birkenfeld, Ian J. Neeland
Circulation (2024) Vol. 150, Iss. 16, pp. 1288-1298
Closed Access | Times Cited: 8
Sarcopenia in MASLD—Eat to Beat Steatosis, Move to Prove Strength
Dana Crișan, Lucreţia Avram, Andreea Morariu-Barb, et al.
Nutrients (2025) Vol. 17, Iss. 1, pp. 178-178
Open Access | Times Cited: 1
Body composition changes during weight reduction with tirzepatide in the SURMOUNT‐1 study of adults with obesity or overweight
Michelle Look, Julia P. Dunn, Robert F. Kushner, et al.
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 1
Prevention and Treatment of Sarcopenic Obesity in Women
Maria Letizia Petroni, Maria Turchese Caletti, Riccardo Dalle Grave, et al.
Nutrients (2019) Vol. 11, Iss. 6, pp. 1302-1302
Open Access | Times Cited: 73
Page 1 - Next Page

Scroll to top